The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Merck Serono; Merck Sharp & Dohme
Speakers' Bureau - Amgen; Merck Serono; Merck Sharp & Dohme; Pierre Fabre; SERVIER
Travel, Accommodations, Expenses - Amgen; SERVIER
 
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Lilly; Merck; Merck Sharp & Dohme; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Gilead Sciences; Lilly; Merck Sharp & Dohme; Sanofi
Travel, Accommodations, Expenses - Gilead Sciences; Roche; Sanofi
 
Speakers' Bureau - AstraZeneca; SERVIER
Research Funding - Novocure
Travel, Accommodations, Expenses - AstraZeneca; Pro.Med.CS; SERVIER
Stereotactic radiotherapy plus anti PD-1 therapy in patients with locally advanced unresectable pancreatic cancer: Results from a phase 1/2 clinical trial (CA209-9KH).
 
Milan Vosmik
Consulting or Advisory Role - Accord Healthcare; AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer
Speakers' Bureau - Gilead Sciences; Merck Sharp & Dohme; Sanofi
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Pfizer
 
John Stanislav
No Relationships to Disclose
 
Josef Dvorak
No Relationships to Disclose
 
Beatrice Mohelníková-Duchoňová
No Relationships to Disclose
 
Bohuslav Melichar
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb/; Merck Serono; MSD
 
Radka Lohynska
No Relationships to Disclose
 
Aleš Ryška
No Relationships to Disclose
 
Johana Krempova
No Relationships to Disclose
 
Igor Sirak
Stock and Other Ownership Interests - BioNTech; Novo Nordisk; Pfizer; Roche
Honoraria - AstraZeneca; GlaxoSmithKline; Merck Sharp & Dohme
Consulting or Advisory Role - GlaxoSmithKline; Merck Sharp & Dohme